Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
27
ACB Quote, Financials, Valuation and Earnings
Last price:
$4.58
Seasonality move
:
-2.41%
Day range:
$4.47 - $4.66
52-week range:
$3.42 - $6.91
Dividend yield:
0%
P/E ratio:
103.35x
P/S ratio:
0.98x
P/B ratio:
0.68x
Volume:
3.8M
Avg. volume:
2.2M
1-year change:
7.03%
Market cap:
$259.1M
Revenue:
$246.8M
EPS (TTM):
-$0.74
Analysts' Opinion
-
Consensus RatingAurora Cannabis, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.34, Aurora Cannabis, Inc. has an estimated upside of 36.25% from its current price of $4.57.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.34 representing 100% downside risk from its current price of $4.57.
Fair Value
-
According to the consensus of 4 analysts, Aurora Cannabis, Inc. has 36.25% upside to fair value with a price target of $6.34 per share.
ACB vs. S&P 500
-
Over the past 5 trading days, Aurora Cannabis, Inc. has underperformed the S&P 500 by -17.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Aurora Cannabis, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aurora Cannabis, Inc. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Aurora Cannabis, Inc. reported revenues of $65.6M.
Earnings Growth
-
Aurora Cannabis, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Aurora Cannabis, Inc. reported earnings per share of -$0.66.
Enterprise value:
258.5M
EV / Invested capital:
0.54x
Price / LTM sales:
0.98x
EV / EBIT:
185.77x
EV / Revenue:
0.98x
PEG ratio (5yr expected):
-0.41x
EV / Free cash flow:
-19.84x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
14.81x
Gross Profit (TTM):
-$2.3M
Return On Assets:
-7.72%
Net Income Margin (TTM):
-17.36%
Return On Equity:
-10.76%
Return On Invested Capital:
-9.18%
Operating Margin:
-61.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $200.4M | $217.7M | $262.6M | $59.5M | $65.6M | |
| Gross Profit | -$13M | -$8M | -$2.3M | $604.9K | -$5.8M | |
| Operating Income | -$133.6M | -$132.8M | -$131.9M | -$30.5M | -$40.7M | |
| EBITDA | -$119.6M | -$113.2M | -$114.9M | -$26.5M | -$36.1M | |
| Diluted EPS | $8.11 | -$0.64 | -$0.74 | -$0.16 | -$0.66 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $512M | $496.2M | $287M | $309.2M | $304.6M | |
| Total Assets | $2B | $851.4M | $605.3M | $598.7M | $544M | |
| Current Liabilities | $94.4M | $122M | $87.3M | $80.8M | $89.2M | |
| Total Liabilities | $419.7M | $418.8M | $199.2M | $167.1M | $136.4M | |
| Total Equity | $1.6B | $432.7M | $406.1M | $431.5M | $407.6M | |
| Total Debt | $266.2M | $236.9M | $93.9M | $74.7M | $72.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$72.8M | -$31.5M | $1.3M | -$18.2M | -$29.3M | |
| Cash From Investing | $38M | -$1.8M | -$12.6M | -$2.7M | -$4.1M | |
| Cash From Financing | -$133.1M | $7.6M | -$1.9M | $2.9M | -$1.2M | |
| Free Cash Flow | -$78M | -$44.8M | -$13M | -$21.6M | -$33.9M | |
ACB
Sector
Market Cap
$259.1M
$28.1M
Price % of 52-Week High
66.28%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.49%
1-Year Price Total Return
8.39%
-17.13%
Beta (5-Year)
0.243
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.15
200-day SMA
Sell
Level
$4.85
Bollinger Bands (100)
Sell
Level
4.5 - 5.46
Chaikin Money Flow
Sell
Level
-1.4B
20-day SMA
Sell
Level
$4.79
Relative Strength Index (RSI14)
Sell
Level
44.79
ADX Line
Buy
Level
20.46
Williams %R
Buy
Level
-87.8455
50-day SMA
Sell
Level
$4.78
MACD (12, 26)
Buy
Level
0.09
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
660.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-9.3104)
Sell
CA Score
(Annual)
Level (-0.4263)
Buy
Beneish M-Score
(Annual)
Level (-2.6766)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.8597)
Buy
Piotroski F Score
(Annual)
Level (9)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Stock Forecast FAQ
In the current month, ACB has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ACB average analyst price target in the past 3 months is $6.34.
-
Where Will Aurora Cannabis, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aurora Cannabis, Inc. share price will rise to $6.34 per share over the next 12 months.
-
What Do Analysts Say About Aurora Cannabis, Inc.?
Analysts are divided on their view about Aurora Cannabis, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aurora Cannabis, Inc. is a Sell and believe this share price will drop from its current level to $6.34.
-
What Is Aurora Cannabis, Inc.'s Price Target?
The price target for Aurora Cannabis, Inc. over the next 1-year time period is forecast to be $6.34 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ACB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aurora Cannabis, Inc. is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of ACB?
You can purchase shares of Aurora Cannabis, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aurora Cannabis, Inc. shares.
-
What Is The Aurora Cannabis, Inc. Share Price Today?
Aurora Cannabis, Inc. was last trading at $4.58 per share. This represents the most recent stock quote for Aurora Cannabis, Inc.. Yesterday, Aurora Cannabis, Inc. closed at $4.57 per share.
-
How To Buy Aurora Cannabis, Inc. Stock Online?
In order to purchase Aurora Cannabis, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ACB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ACB
Sector
P/E ratio
103.35x
23.89x
PEG ratio
-0.41x
-0.01x
P/B ratio
0.68x
1.81x
Price / LTM sales
0.98x
1.59x
Growth Metrics
ACB
Sector
Revenue growth
10.32%
4.62%
Earnings growth
-301.94%
11.06%
Revenue (5-year growth)
5.88%
6.5%
Earnings forecast
-$0.02
-$0.21
Profitability
ACB
Sector
Profitability FY 2024
$2.3M
$3.6M
Return on invested capital
-9.18%
-31.84%
Return on assets
-7.72%
-27.96%
Return on equity
-10.76%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
ACB
Sector
Total cash
$102M
$26.4M
Short term investments
$387.1K
$25.7M
Total assets
$592.4M
$76.9M
Long term debt
$72.1M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
